Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cytox AS
AS
Active
Org 928694542
Nedre Nøttveit 58, 5238
Rådal
Skadedyrkontroll
·
NACE 81291
Est. 2022 · 4 years old
9 employees
Monitor
Share
Norway
/
Companies
/
Skadedyrkontroll
/
Cytox AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
19M
14M
9M
5M
0M
2022: 15M
15M
2022
2023: 15M (0% vs 2022)
15M
0%
2023
2024: 15M (0% vs 2023)
15M
0%
2024
EBITDA
NOK millions
2M
2M
1M
1M
0M
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
Income statement
NOK thousands
Item
2024
2023
2022
Revenue
14 580
14 974
14 747
Staff expenses
−9 465
−10 104
−9 730
EBITDA
1 542
777
875
Depreciation & amort.
−69
−67
−79
EBIT
1 473
710
795
Net financials
70
2
6
Profit before tax
1 543
712
802
Tax
340
157
221
Net profit
1 203
555
581
Balance sheet
NOK thousands
Item
2024
2023
2022
Total assets
8 979
8 056
8 258
Equity
1 609
1 756
1 751
Long-term debt
0
38
91
Short-term debt
7 370
6 262
6 416
Total debt
7 370
6 300
6 507
Financial ratios
5-year trend
EBITDA margin
10,6 %
This company
15,8 %
Market median
This company
Market median
33% below market
2022
2024
Equity ratio
17,9 %
This company
38,2 %
Market median
This company
Market median
53% below market
2022
2024
Return on equity
74,8 %
This company
18,4 %
Market median
This company
Market median
307% above market
2022
2024
Net profit margin
8,2 %
This company
8,1 %
Market median
This company
Market median
1% above market
2022
2024
Asset turnover
1,62×
This company
1,12×
Market median
This company
Market median
45% above market
2022
2024
Debt / equity
4,58×
This company
0,62×
Market median
This company
Market median
639% above market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
More on Cytox AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network